Literature DB >> 20019828

In children with idiopathic short stature, what advantage does administering recombinant growth hormone have over observation in final adult height?: Part B: Clinical commentary.

Seth D Marks1.   

Abstract

Entities:  

Year:  2003        PMID： 20019828      PMCID： PMC2794322     

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  3 in total

Review 1.  Safety issues in children and adolescents during growth hormone therapy--a review.

Authors:  P E Clayton; C T Cowell
Journal:  Growth Horm IGF Res       Date:  2000-12       Impact factor: 2.372

2.  Quality of life of young adults with idiopathic short stature: effect of growth hormone treatment. Dutch Growth Hormone Working Group.

Authors:  L T Rekers-Mombarg; J J Busschbach; G G Massa; J Dicke; J M Wit
Journal:  Acta Paediatr       Date:  1998-08       Impact factor: 2.299

Review 3.  Therapeutic controversies: growth hormone (GH) treatment of non-GH deficient subjects.

Authors:  D B Allen; C G Brook; N A Bridges; P C Hindmarsh; H J Guyda; D Frazier
Journal:  J Clin Endocrinol Metab       Date:  1994-11       Impact factor: 5.958
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.